小児インフルエンザ治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2676)
◆英語タイトル:Global Pediatric Influenza Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2676
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、小児インフルエンザ治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他)、用途別市場規模(病院、クリニック、外来手術センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・小児インフルエンザ治療の市場動向
・企業の競争状況、市場シェア
・小児インフルエンザ治療の種類別市場規模(抗ウイルス薬、解熱剤、ノイラミニダーゼ阻害剤、その他)
・小児インフルエンザ治療の用途別市場規模(病院、クリニック、外来手術センター、その他)
・小児インフルエンザ治療の北米市場規模2016-2027(アメリカ、カナダ)
・小児インフルエンザ治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・小児インフルエンザ治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・小児インフルエンザ治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・小児インフルエンザ治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc.、NATCO Pharma Limited.、NESHER PHARMS、Johnson & Johnsons Inc.、Cipla、Hetero Pharma、Teva Pharmaceutical pvt. Ltd.、Olainfarm JSC、Gilead Sciences, Inc.)
・結論
【レポートの概要】

Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.

Market Analysis and Insights: Global Pediatric Influenza Treatment Market
The global Pediatric Influenza Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Influenza Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Influenza Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Influenza Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Influenza Treatment market.

Global Pediatric Influenza Treatment Scope and Market Size
Pediatric Influenza Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Influenza Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Influenza Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antiviral Drug
1.2.3 Antipyretic
1.2.4 Neuraminidase inhibitor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pediatric Influenza Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Influenza Treatment Market Perspective (2016-2027)
2.2 Pediatric Influenza Treatment Growth Trends by Regions
2.2.1 Pediatric Influenza Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric Influenza Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric Influenza Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric Influenza Treatment Industry Dynamic
2.3.1 Pediatric Influenza Treatment Market Trends
2.3.2 Pediatric Influenza Treatment Market Drivers
2.3.3 Pediatric Influenza Treatment Market Challenges
2.3.4 Pediatric Influenza Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Influenza Treatment Players by Revenue
3.1.1 Global Top Pediatric Influenza Treatment Players by Revenue (2016-2021)
3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric Influenza Treatment Revenue
3.4 Global Pediatric Influenza Treatment Market Concentration Ratio
3.4.1 Global Pediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Influenza Treatment Revenue in 2020
3.5 Pediatric Influenza Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Influenza Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Influenza Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Influenza Treatment Breakdown Data by Type
4.1 Global Pediatric Influenza Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pediatric Influenza Treatment Forecasted Market Size by Type (2022-2027)

5 Pediatric Influenza Treatment Breakdown Data by Application
5.1 Global Pediatric Influenza Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pediatric Influenza Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric Influenza Treatment Market Size (2016-2027)
6.2 North America Pediatric Influenza Treatment Market Size by Type
6.2.1 North America Pediatric Influenza Treatment Market Size by Type (2016-2021)
6.2.2 North America Pediatric Influenza Treatment Market Size by Type (2022-2027)
6.2.3 North America Pediatric Influenza Treatment Market Size by Type (2016-2027)
6.3 North America Pediatric Influenza Treatment Market Size by Application
6.3.1 North America Pediatric Influenza Treatment Market Size by Application (2016-2021)
6.3.2 North America Pediatric Influenza Treatment Market Size by Application (2022-2027)
6.3.3 North America Pediatric Influenza Treatment Market Size by Application (2016-2027)
6.4 North America Pediatric Influenza Treatment Market Size by Country
6.4.1 North America Pediatric Influenza Treatment Market Size by Country (2016-2021)
6.4.2 North America Pediatric Influenza Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediatric Influenza Treatment Market Size (2016-2027)
7.2 Europe Pediatric Influenza Treatment Market Size by Type
7.2.1 Europe Pediatric Influenza Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pediatric Influenza Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pediatric Influenza Treatment Market Size by Type (2016-2027)
7.3 Europe Pediatric Influenza Treatment Market Size by Application
7.3.1 Europe Pediatric Influenza Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pediatric Influenza Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pediatric Influenza Treatment Market Size by Application (2016-2027)
7.4 Europe Pediatric Influenza Treatment Market Size by Country
7.4.1 Europe Pediatric Influenza Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pediatric Influenza Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric Influenza Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Type
8.2.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Application
8.3.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric Influenza Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric Influenza Treatment Market Size by Region
8.4.1 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric Influenza Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric Influenza Treatment Market Size (2016-2027)
9.2 Latin America Pediatric Influenza Treatment Market Size by Type
9.2.1 Latin America Pediatric Influenza Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric Influenza Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric Influenza Treatment Market Size by Type (2016-2027)
9.3 Latin America Pediatric Influenza Treatment Market Size by Application
9.3.1 Latin America Pediatric Influenza Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric Influenza Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric Influenza Treatment Market Size by Application (2016-2027)
9.4 Latin America Pediatric Influenza Treatment Market Size by Country
9.4.1 Latin America Pediatric Influenza Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric Influenza Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric Influenza Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type
10.2.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application
10.3.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric Influenza Treatment Market Size by Country
10.4.1 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 GlaxoSmithKline Plc.
11.2.1 GlaxoSmithKline Plc. Company Details
11.2.2 GlaxoSmithKline Plc. Business Overview
11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Introduction
11.2.4 GlaxoSmithKline Plc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Plc. Recent Development
11.3 NATCO Pharma Limited.
11.3.1 NATCO Pharma Limited. Company Details
11.3.2 NATCO Pharma Limited. Business Overview
11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Introduction
11.3.4 NATCO Pharma Limited. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.3.5 NATCO Pharma Limited. Recent Development
11.4 NESHER PHARMS
11.4.1 NESHER PHARMS Company Details
11.4.2 NESHER PHARMS Business Overview
11.4.3 NESHER PHARMS Pediatric Influenza Treatment Introduction
11.4.4 NESHER PHARMS Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.4.5 NESHER PHARMS Recent Development
11.5 Johnson & Johnsons Inc.
11.5.1 Johnson & Johnsons Inc. Company Details
11.5.2 Johnson & Johnsons Inc. Business Overview
11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Introduction
11.5.4 Johnson & Johnsons Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.5.5 Johnson & Johnsons Inc. Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Pediatric Influenza Treatment Introduction
11.6.4 Cipla Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Details
11.7.2 Hetero Pharma Business Overview
11.7.3 Hetero Pharma Pediatric Influenza Treatment Introduction
11.7.4 Hetero Pharma Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.7.5 Hetero Pharma Recent Development
11.8 Teva Pharmaceutical pvt. Ltd.
11.8.1 Teva Pharmaceutical pvt. Ltd. Company Details
11.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview
11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Introduction
11.8.4 Teva Pharmaceutical pvt. Ltd. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.8.5 Teva Pharmaceutical pvt. Ltd. Recent Development
11.9 Olainfarm JSC
11.9.1 Olainfarm JSC Company Details
11.9.2 Olainfarm JSC Business Overview
11.9.3 Olainfarm JSC Pediatric Influenza Treatment Introduction
11.9.4 Olainfarm JSC Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.9.5 Olainfarm JSC Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Pediatric Influenza Treatment Business (2016-2021)
11.10.5 Gilead Sciences, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 小児インフルエンザ治療の世界市場規模・現状・予測2021年-2027年(Global Pediatric Influenza Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。